PINE BLUFF, Ark., Nov. 30, 2016 -- Simmons First National Corp.’s (NASDAQ:SFNC) board of directors declared a regular $0.24 per share quarterly cash dividend payable Jan. 3, 2017, to shareholders of record Dec. 15, 2016. This dividend represents a $0.01 per share, or 4.3 percent, increase above the dividend paid for the same period last year.
Simmons First National Corp. is a financial holding company, headquartered in Pine Bluff, Ark., with total assets of $8.2 billion conducting financial operations throughout Arkansas, Kansas, Missouri and Tennessee. The company through its subsidiaries offers comprehensive financial solutions delivered with a client-centric approach. The company’s common stock trades on the NASDAQ Global Select Market under the symbol “SFNC.”
FOR MORE INFORMATION CONTACT: J. BURTON HICKS SVP - Investor Relations Officer Simmons First National Corporation (870) 541-1000


OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
First Western Ship Transits Strait of Hormuz Since Iran War Began
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



